| 000 | 01615 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517190633.0 | ||
| 264 | 0 | _c20180730 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1756-0500 | ||
| 024 | 7 |
_a10.1186/s13104-017-3022-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarango, Sylvia Naliaka | |
| 245 | 0 | 0 |
_aExperimental therapeutic assays of Tephrosia vogelii against Leishmania major infection in murine model: in vitro and in vivo. _h[electronic resource] |
| 260 |
_bBMC research notes _cDec 2017 |
||
| 300 |
_a698 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAmphotericin B _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimony Sodium Gluconate _xtherapeutic use |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _xdrug therapy |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 |
_aPlant Extracts _xtherapeutic use |
| 650 | 0 | 4 |
_aSpleen _xdrug effects |
| 650 | 0 | 4 |
_aTephrosia _xchemistry |
| 700 | 1 | _aKhayeka-Wandabwa, Christopher | |
| 700 | 1 | _aMakwali, Judith Alice | |
| 700 | 1 | _aJumba, Bernard Ngoitsi | |
| 700 | 1 | _aChoge, Joseph K | |
| 700 | 1 | _aAdino, Eric Onyango | |
| 700 | 1 | _aAnjili, Christopher O | |
| 773 | 0 |
_tBMC research notes _gvol. 10 _gno. 1 _gp. 698 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13104-017-3022-x _zAvailable from publisher's website |
| 999 |
_c27857125 _d27857125 |
||